NL
PPH icon

NVWM LLC’s VanEck Pharmaceutical ETF PPH Stock Holding History

NVWM LLC’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-38
Closed -$3.32K – 692
2025
Q2 		$3.32K Buy
+38
New +$3.29K ﹤0.01% 368
2022
Q3 		– Sell
-9,776
Closed -$751K – 475
2022
Q2 		$751K Buy
+9,776
New +$763K 0.29% 114
2020
Q1 		– Sell
-69
Closed -$4K – 368
2019
Q4 		$4K Sell
69
-19
-22% -$1.15K ﹤0.01% 277
2019
Q3 		$5K Sell
88
-8,775
-99% -$503K ﹤0.01% 300
2019
Q2 		$520K Buy
8,863
+1,023
+13% +$59.2K 0.31% 111
2019
Q1 		$476K Sell
7,840
-124
-2% -$7.33K 0.32% 108
2018
Q4 		$438K Buy
+7,964
New +$482K 0.33% 100
2018
Q3 		– Sell
-1,502
Closed -$89K – 363
2018
Q2 		$89K Hold
1,502
– – 0.06% 155
2018
Q1 		$82K Buy
1,502
+190
+14% +$11.4K 0.06% 161
2017
Q4 		$78K Buy
+1,312
New +$75.2K 0.06% 157

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

NVWM LLC's PPH Position: Q3 2025 in Review

NVWM LLC sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2025, closing a stake of 38 shares — an estimated $3.32K sold.

NVWM LLC first reported a position in PPH in Q4 2017 and held it in 10 quarters. The position peaked at $751K in Q2 2022. 127 funds tracked by Wall St. Rank hold PPH as of Q3 2025.

  • NVWM LLC reported no remaining VanEck Pharmaceutical ETF position as of Q3 2025 after selling out during the quarter.
  • NVWM LLC sold 38 VanEck Pharmaceutical ETF shares in Q3 2025, an estimated $3.32K.
  • NVWM LLC first reported a position in VanEck Pharmaceutical ETF in Q4 2017 and held it in 10 quarters.
  • NVWM LLC's VanEck Pharmaceutical ETF position peaked at $751K in Q2 2022.
  • 127 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2025.

Based on NVWM LLC's 13F filing for Q3 2025, filed 16 Oct 2025.